CompletedNCT03005769
Predictors of Staying on Monthly Aripiprazole in Italian Clinical Practice
About this title
Read the official source — NCT03005769Observational studyAges 18+ItalySchizophrenia
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- Ancona and 19 more locationsSee all locations and recruitment
Study information
Study start dateStarted: December 2016
- Recruitment status
- Completed
- Enrollment listed in the registry
- 262
- Sponsor
- Otsuka Pharmaceutical Europe Ltd
- Sponsor type
- Pharmaceutical company
- Study type
- Observational
- Intervention type
- Interview / survey / observational
- Locations
- Italy
- Age range
- Over 18 Years
- Official registry ID
- NCT03005769
- Official title
Show the full official title
Demographic and Clinical Predictors of Persistence in Patients Treated With Aripiprazole Once-monthly in the Italian Clinical Practice: a Retrospective Cohort, Observational Study
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Ancona · Brescia · Cagliari
16 more locations
- Catania
- Catanzaro
- Florence
- Genzano di Roma
- Giulianova
- Lecce
- Milan
- Monza
- Orbassano
- Padova
- Palermo
- Perugia
- Pomezia
- Pontecagnano
- Siena
- Treviso
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Otsuka Pharmaceutical Europe Ltd, a pharmaceutical company.
Who was this study for?
Listed age limits: from 18 years.
